method and composition for increasing the absorption and the bioavailability of hydrophobic drugs in the gastro intestinal tract

• 1. 用于增加黑参提取物中人参皂苷的生物利用度以及促进其吸收的组合物 [P] . 中国专利： CN113905751A . 2022-01-07
• 2. 用于增加疏水性药物溶解度的药物组合物 [P] . 中国专利： CN1856297A . 2006-11-01
• 3. method and composition for increasing the absorption and the bioavailability of hydrophobic drugs in the gastro intestinal tract [P] . 德国专利： DE60332721D1 . 2010-07-08

  机译： 胃肠道中增加疏水性药物吸收和生物利用度的方法和组合物

• 4. Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs [P] . 美国专利： US9107825B2 . 2015-08-18

  机译： 增强疏水性药物吸收和胃肠道生物利用度的方法和制剂

• 5. METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND GASTRO-INTESTINAL BIOAVAILABILITY OF HYDROPHOBIC DRUGS [P] . 美国专利： US2013108689A1 . 2013-05-02

  机译： 增强药物吸收和胃肠道生物利用度的方法和公式

• 1. INFLAMMATORY FIBROID POLYPS OF GASTRO-INTESTINAL TRACT [J] . 中国癌症研究（英文版） . 2000,第002期
• 2. Intestinal OCTN2-and MCT1-targeted drug delivery to improve oral bioavailability [J] . Gang Wang, Lichun Zhao, Qikun jiang, 亚洲药物制剂科学(英文) . 2020,第002期
• 3. Scientific Opinion on the substantiation of health claims related to fructooligosaccharides (FOS) from sucrose and decreasing potentially pathogenic gastro intestinal microorganisms (ID 774), changes in short chain fatty acid (SCFA) production and pH in the gastro‐intestinal tract (ID 775), changes in bowel function (ID 775, 778), reduction of gastro intestinal discomfort (ID 775, 778), increase in calcium and/or magnesium absorption leading to an increase in magnesium and/or calcium retention (ID 776, 777), maintenance of normal blood LDL cholesterol concentrations (ID 805) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 805) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 [J] . EFSA Journal . 2011,第4期
• 4. Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract. [J] . Kobayashi M, Sada N, Sugawara M, International Journal of Pharmaceutics . 2001,第1a2期
• 5. The survey of the use of qsar methods to determine intestinal absorption and oral bioavailability during drug design [J] . SilvaF.T., TrossiniG.H.G. Medicinal chemistry . 2014,第5期
• 6. Novel fluorescent oxides provide insight into dynamics of nanoparticle- mediated drug uptake from gastro-intestinal tract [C] . Waldemar Lipinski, Aleksandra Ozogowska, Jaroslaw Kaszewski, SPIE Photonics Europe Conference . 2018
• 7. Absorption and toxicity of drugs in intestinal tract. [D] . Bramer, Steven Lee. 1992
• 8. The effect of water on the absorption of drugs from the gastro-intestinal tract. [O] . G Williams, J L Maddocks 1975
• 9. Studies on the Metabolic Fate of Flutamide. (4): Biliary Excretion, Enterohepatic Circulation, Absorption from Gastro-intestinal Tract, Metabolism and Drug-Metabolizing Enzymes Induction in Rats. [O] . Noriko ASAKAWA, Michinori KOYAMA, Yutaka HASHIMOTO, 1995
• 10. Protein Digestion and Absorption by the Entire Gastro-Intestinal Tract in Man. [R] . Phillips, R. A. 1975

• 1. New approaches to increase intestinal length: Methods used for intestinal regeneration and bioengineering [J] . Ali Shirafkan ,Mauro Montalbano ,Joshua Mc Guire . 世界移植杂志 . 2016,第1期
• 2. Study on the Effects of Increasing Production Rate of Ruminal Acetate and Butyrate on Their Absorption and Passage in Alimentary Tract of Sheep [J] . DU Rui-ping ,LU De-xun . 畜牧与饲料科学 . 2011,第009期
• 3. Study on the Effects of Increasing Production Rate of Ruminal Acetate and Butyrate on Their Absorption and Passage in Alimentary Tract of Sheep [J] . DU Rui-ping ,LU De-xun . 畜牧与饲料科学 . 2011,第010期
• 4. 增加组合体读图趣味性的方法 [C] . 赵炳利 ,闫善民 . 纪念中国工程图学学会成立二十周年暨学术会议 . 1999
• 5. 不同铜源在雏鸡消化道中生物利用度及吸收方式的比较研究 [A] . 崔勇 . 2018